SCOPUS 정보 검색 플랫폼

British Journal of Haematology

Volumn 91, Issue 3, 1995, Pages 652-657

Decreased potency of MDR‐modulators under serum conditions determined by a functional assay

(5) Ludescher, Christof a Eisterer, Wolfgang a Hilbe, Wolfgang a Hofmann, Johann b Thaler, Josef a

a UNIVERSITY OF INNSBRUCK (Austria)

b UNIVERSITY OF INNSBRUCK (Austria)

Author keywords

bioavailability; MDR modulators; multidrug resistance; rhodamine 123

Indexed keywords

CYCLOSPORIN A; DEXNIGULDIPINE; MIDOSTAURIN; RHODAMINE 123; VALSPODAR; VERAPAMIL;

ARTICLE; B CELL LEUKEMIA; BIOAVAILABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NORMAL HUMAN; PRIORITY JOURNAL;

ACUTE DISEASE; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CYCLOSPORINE; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; FLOW CYTOMETRY; HUMAN; LEUKEMIA, B-CELL, CHRONIC; LEUKEMIA, MYELOID; P-GLYCOPROTEIN; RHODAMINE 123; RHODAMINES; VERAPAMIL;

EID: 0028885630 PISSN: 00071048 EISSN: 13652141 Source Type: Journal
DOI: 10.1111/j.1365-2141.1995.tb05362.x Document Type: Article

Times cited : (32)

References (28)

1
- 0028199806
- Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance
- (1994) Journal of Clinical Oncology , vol.12 , pp. 835-842
- Bartlett, N.L.¹ Lum, B.L.² Fisher, G.A.³ Brophy, N.A.⁴ Ehsan, M.⁵ Halsey, J.⁶ Sikic, B.I.⁷

2
- 85005084533
- R‐verapamil reverses drug resistance in some relapsed lymphoma patients. (Abstract)
- (1994) Anticancer Drugs , vol.5 , pp. 73
- Bates, S.¹ Wilson, W.² Fojo, T.³ Wittes, R.⁴ Bryant, G.⁵ Chabner, B.⁶

3
- 0026014503
- In vivo circumvention of P‐glycoprotein‐mediated multidrug resistance of tumour cells with SDZ PSC 833
- (1991) Cancer Research , vol.51 , pp. 4226-4233
- Boesch, D.¹ Gaveriaux, C² Jachez, B.³ Pourtier‐Manzanedo, A.⁴ Bollinger, P.⁵ Loor, I.⁶

4
- 0026465461
- Expression and activity of the multidrug resistance P‐glycoprotein in human peripheral blood lymphocytes
- (1992) Blood , vol.80 , pp. 2735-2739
- Chaudhary, P.M.¹ Mechetner, E.B.² Roninson, LB.³

5
- 0024506222
- Drug‐resistance in multiple myeloma and non‐Hodgkin's lymphoma: detection of P‐glycoprotein and potential circumvention by addition of verapamil to chemotherapy
- (1989) Journal of Clinical Oncology , vol.7 , pp. 415-424
- Dalton, W.S.¹ Grogan, T.M.² Meltzer, P.S.³ Scheper, R.J.⁴ Durie, B.G.M.⁵ Taylor, C.W.⁶ Miller, T.P.⁷ Salmon, S.E.⁸

6
- 0345696326
- SDZ PSC 833 in combination with doxorubicin: a phase I and pharmacologic study in solid tumors. (Abstract)
- (1994) Anticancer Drugs , vol.5 , pp. 43
- Giaccone, G.¹ Linn, S.C.² Catimel, G.³ Dumortier, A.⁴ Foy, M.⁵ Vermorken, J.B.⁶ Koier, I.⁷ Welink, J.⁸ van der Vijgh, W.⁹ Eeltnik, C¹⁰ Laburte, C.¹¹ Pinedo, H.M.¹²

7
- 0026583333
- Reversal of multidrug resistance by B859‐35, a metabolite of B859‐35, niguldipine, verapamil and nitrendipine
- (1992) Journal of Cancer Research and Clinical Oncology , vol.118 , pp. 361-366
- Hofmann, J.¹ Wolf, A.² Spitaler, M.³ Bock, G.⁴ Drach, J.⁵ Ludescher, C.⁶ Grunicke, H.⁷

8
- 0028030228
- Rhodamine efflux patterns predict P‐glycoprotein substrates in the National Cancer Institute drug screen
- (1994) Molecular Pharmacology , vol.46 , pp. 627-638
- Lee, J.S.¹ Paull, K.² Alvarez, M.³ Hose, C.⁴ Monks, A.⁵ Grever, M.⁶ Fojo, A.T.⁷ Bates, S.⁸

9
- 85004906573
- In vivo concentration of serum proteins significantly inhibits reversal of P‐glycoprotein‐mediated drug resistance by some chemosensitizers. (Abstract)
- (1990) Proceedings of the American Association for Cancer Research , vol.31 , pp. 379
- Lehnert, M.¹ Kunko, K.² Dalton, W.S.³ Roe, D.⁴ Dorr, R.T.⁵ Salmon, S.E.⁶

10
- 0027274736
- Phase I/II trial of cyclosporine as a chemotherapy‐resistance modifier in acute leukemia
- (1993) Journal of Clinical Oncology , vol.11 , pp. 1652-1660
- List, A.F.¹ Spier, C.² Greer, J.³ Wolff, S.⁴ Hutter, J.⁵ Dorr, R.⁶ Salmon, S.⁷ Futscher, B.⁸ Baier, M.⁹ Dalton, W.¹⁰

11
- 0027377649
- Activity of P‐glycoprotein in B‐cell chronic lymphocytic leukemia determined by a flow cytometric assay
- (1993) Journal of the National Cancer Institute , vol.85 , pp. 1751-1758
- Ludescher, C¹ Hilbe, W.² Eisterer, W.³ Preuss, E.⁴ Huber, C⁵ Gotwald, M.⁶ Hofmann, J.⁷ Thaler, J.⁸

12
- 0026668717
- Detection of activity of P‐glycoprotein in human tumour samples using rhodamine 123
- (1992) British Journal of Uaematology , vol.82 , pp. 161-168
- Ludescher, C¹ Thaler, J.² Drach, D.³ Drach, J.⁴ Spitaler, M.⁵ Gattringer, C⁶ Huber, H.⁷ Hofmann, J.⁸

13
- 0027538652
- Molecular targets in oncology: implications of the multidrug resistance gene
- (1993) Pharmacotherapy , vol.13 , pp. 88-109
- Lum, B.L.¹ Gosland, M.P.² Kaubisch, S.³ Sikic, B.I.⁴

14
- 0027067753
- Alteration of etoposide pharmacokinetics and pharamcodynamics by cyclosporine in a phase I trial to modulate multidrug resistance
- (1992) Journal of Clinical Oncology , vol.10 , pp. 1635-1642
- Lum, B.L.¹ Kaubisch, S.² Yahanda, A.M.³ Adler, K.M.⁴ Jew, L.⁵ Ehsan, M.N.⁶ Brophy, N.A.⁷ Halsey, J.⁸ Gosland, M.P.⁹ Sikic, B.I.¹⁰

15
- 0028560376
- Clinical reversal of the multidrug resistance phenotype: true tumour modulation or pharmacokinetic interaction
- (1994) European Journal of Cancer , vol.30 , pp. 2039-2041
- McLeod, H.L.¹

16
- 0024379951
- A derivative of staurosporine (CGP 41251) shows selectivity for protein kinase C inhibition and in vitro anti‐proliferative as well as in vivo anti‐tumor activity
- (1989) International Journal of Cancer , vol.43 , pp. 851-856
- Meyer, T.¹ Regenass, U.² Fabbro, D.³ Alteri, E.⁴ Rosel, J.⁵ Muller, M.⁶ Caravatti, G.⁷ Matter, A.⁸

17
- 0007829986
- Southwest Oncology Group clinical trials of chemosensitizers in non‐Hodgkin's lymphomas. (Abstract)
- (1994) Anti-Cancer Drugs , vol.5 , pp. 73
- Miller, T.P.¹ Dahlberg, S.² Grogan, T.M.³ Fisher, R.I.⁴

18
- 0026051296
- P‐glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high‐dose verapamil
- (1991) Journal of Clinical Oncology , vol.9 , pp. 17-24
- Miller, T.P.¹ Grogan, T.M.² Dalton, W.S.³ Spier, CM.⁴ Scheper, R.J.⁵ Salmon, S.E.⁶

19
- 0028269030
- Clinical relevance of P‐glycoprotein in haematological malignancies
- (1994) Leukemia Research , vol.18 , pp. 233-243
- Nooter, K.¹ Sonneveld, P.²

20
- 0023233801
- Multiple‐drug resistance in human cancer. New
- (1987) England Journal of Medicine , vol.316 , pp. 1388-1393
- Pastan, I.¹ Gottesman, M.²

21
- 0024398797
- Multidrug resistance: molecular biology and clinical relevance
- (1989) Journal of the National Cancer Institute , vol.81 , pp. 907-910
- Rothenberg, M.¹ Ling, V.²

22
- 0025821275
- Multidrug‐resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer
- (1991) Blood , vol.78 , pp. 44-50
- Salmon, S.E.¹ Dalton, W.S.² Grogan, T.M.³ Plezia, P.⁴ Lehnert, M.⁵ Roe, D.J.⁶ Miller, T.P.⁷

23
- 0026634681
- Modulation of multidrug‐resistant multiple myeloma by cyclosporin
- (1992) lancet , vol.340 , pp. 255-259
- Sonneveld, P.¹ Durie, B.G.M.² Lokhorst, H.M.³ Marie, J.⁴ Solbu, G.⁵ Suciu, S.⁶ Zittoun, R.⁷ Lowenberg, B.⁸ Nooter, K.⁹

24
- 4244132134
- Modulation of multidrug resistance (MDR1) by dexniguldipine‐HCl in combination with VAD or VECD in patients with refractory myeloma
- (1993) Annals of Hematology , vol.67 , pp. 492a
- Thaler, J.¹ Reiter, W.² Ludescher, C³ Wormann, B.⁴ Nussler, V.⁵ Gattringer, C⁶ Reiber, C⁷ Weimar, C.⁸ Nowrousian, M.R.⁹

25
- 0028231242
- The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity reverses multidrug resistance
- (1994) International Journal of Cancer , vol.57 , pp. 104-110
- Utz, I.¹ Hofer, S.² Regenass, U.³ Hilbe, W.⁴ Thaler, J.⁵ Grunicke, H.⁶ Hofmann, J.⁷

26
- 0028020860
- Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo‐controlled randomized trial
- (1994) Journal of Clinical Oncology , vol.12 , pp. 1771-1777
- Wishart, G.C.¹ Bisset, D.² Paul, J.³ Jodrell, D.⁴ Harnett, A.⁵ Habeshaw, T.⁶ Kerr, D.J.⁷ Macham, M.A.⁸ Soukop, M.⁹ Leonard, R.C.F.¹⁰ Knepil, J.¹¹ Kaye, S.B.¹²

27
- 0026517410
- Adequate tumour quinidine levels for multidrug resistance modulation can be achieved in
- (1992) vivo. European Journal of Cancer , vol.28 , pp. 28-31
- Wishart, G.C.¹ Plump, J.A.² Morrison, J.G.³ Hamilton, T.G.⁴ Kaye, S.B.⁵

28
- 0028116322
- Multidrug resistance in lymphomas
- (1994) Journal of Clinical Oncology , vol.12 , pp. 2453-2459
- Yuen, A.R.¹ Sikic, B.I.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.